As the CAD-associated risk variant—which leads to a lack of wild-type SVEP1 in patients—elevated CXCL1 expression and Svep1-deficient mice showed enlarged plaque sizes, we wondered whether SVEP1 directly impacts endothelial CXCL1 expression. This evidence concerns the gene SVEP1 and coronary artery disorder.